Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K KRAMER

Showing results (81-90 of 620) with videos related to

Pageof 62
Sort By:
Oncogene|December 22, 2015
Tumor suppressor control of the cancer stem cell nicheK Kramer, J Wu, D L Crowe
The Journal of Clinical Endocrinology and Metabolism|November 7, 2015
Response to the Letter by Kalra S. et alC K Kramer, B Zinman, R Retnakaran
Diabetes Care|August 23, 2014
Response to comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082Caroline K Kramer, Ravi Retnakaran, Bernard Zinman
Ebiomedicine|October 9, 2024
Next-gen spinal cord injury clinical trials: lessons learned and opportunities for future successPaulina S Scheuren, John L K Kramer
Annals of Ophthalmology|March 1, 1991
Intraocular irrigating solutions: a clinical study of BSS plus and dextrose bicarbonate lactated Ringer's solutionK K Kramer, T Thomassen, J Evaul
Annals of Internal Medicine|December 4, 2013
Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysisCaroline K Kramer, Bernard Zinman, Ravi Retnakaran
Diabetes Care|January 24, 2015
Response to Comment on Retnakaran et al. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care 2014;37:3270-3278Ravi Retnakaran, Caroline K Kramer, Bernard Zinman
Diabetologia|March 8, 2019
Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysisCaroline K Kramer, Sara Campbell, Ravi Retnakaran
Postgraduate Medical Journal|November 4, 2000
Sweet's syndrome in association with Crohn's diseaseA Vaz, K Kramer, R A Kalish
JACC. Heart Failure|December 1, 2018
Reply: Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering DrugsCaroline K Kramer, Chang Ye, Ravi Retnakaran
Pageof 62

Showing results (81-90 of 620) with videos related to

Sort By:
Pageof 62
Oncogene|December 22, 2015
Tumor suppressor control of the cancer stem cell nicheK Kramer, J Wu, D L Crowe
The Journal of Clinical Endocrinology and Metabolism|November 7, 2015
Response to the Letter by Kalra S. et alC K Kramer, B Zinman, R Retnakaran
Diabetes Care|August 23, 2014
Response to comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082Caroline K Kramer, Ravi Retnakaran, Bernard Zinman
Ebiomedicine|October 9, 2024
Next-gen spinal cord injury clinical trials: lessons learned and opportunities for future successPaulina S Scheuren, John L K Kramer
Annals of Ophthalmology|March 1, 1991
Intraocular irrigating solutions: a clinical study of BSS plus and dextrose bicarbonate lactated Ringer's solutionK K Kramer, T Thomassen, J Evaul
Annals of Internal Medicine|December 4, 2013
Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysisCaroline K Kramer, Bernard Zinman, Ravi Retnakaran
Diabetes Care|January 24, 2015
Response to Comment on Retnakaran et al. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care 2014;37:3270-3278Ravi Retnakaran, Caroline K Kramer, Bernard Zinman
Diabetologia|March 8, 2019
Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysisCaroline K Kramer, Sara Campbell, Ravi Retnakaran
Postgraduate Medical Journal|November 4, 2000
Sweet's syndrome in association with Crohn's diseaseA Vaz, K Kramer, R A Kalish
JACC. Heart Failure|December 1, 2018
Reply: Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering DrugsCaroline K Kramer, Chang Ye, Ravi Retnakaran
Pageof 62